Chow Josephine, Rayment Glenda, Wong Jeff, Jefferys Andrew, Suranyi Michael
Cardiovascular Stream, Sydney South West Area Health Service, New South Wales, Australia.
J Ren Care. 2009 Sep;35(3):120-6. doi: 10.1111/j.1755-6686.2009.00093.x.
Needle-stick injury (NSI) is a major occupational health and safety issue facing healthcare professionals. The administration of erythropoiesis-stimulating agents (ESA) in haemodialysis patients represents a major cause for injections. The purpose of this initiative was to familiarise nursing staff with needle-free administration of an ESA in haemodialysis patients to reduce the risk of NSI. Epoetin beta comes in a commercial presentation with a detached needle. Epoetin beta was administered to 10 haemodialysis patients via the venous bubble trap short line of the haemodialysis circuit. An audit was conducted that included a retrospective assessment of NSI for the previous six months; and a prospective assessment for eight weeks to assess whether there is a nursing staff preference for needle-free administration of ESA. There were no reports of NSI in the needle-free group. Haemoglobin levels were maintained. Ninety-one percent of the nursing staff preferred needle-free administration of ESA. In conclusion, the commercial presentation of epoetin beta with the detached needle presents an opportunity to reduce the potential risk of NSI in haemodialysis units.
针刺伤（NSI）是医护人员面临的一个主要职业健康与安全问题。在血液透析患者中使用促红细胞生成素（ESA）是注射的一个主要原因。该倡议的目的是让护理人员熟悉在血液透析患者中无针注射ESA，以降低针刺伤的风险。促红细胞生成素β有带分离针头的商用制剂。通过血液透析回路的静脉气泡捕捉短管，对10名血液透析患者给予促红细胞生成素β。进行了一项审计，包括对前六个月针刺伤的回顾性评估；以及为期八周的前瞻性评估，以评估护理人员是否倾向于无针注射ESA。无针注射组没有针刺伤报告。血红蛋白水平得以维持。91%的护理人员倾向于无针注射ESA。总之，带分离针头的促红细胞生成素β商用制剂为降低血液透析单位针刺伤的潜在风险提供了一个机会。
